Recent Advances on Small-Molecule Antagonists Targeting TLR7 by Haoyang Zheng, Peiyang Wu, Pierre-Antoine Bonnet

Get full text

Imidazo[1,2-<i>a</i>]quinoxalines Derivatives Grafted with Amino Acids: Synthesis and Evaluation on A375 Melanoma Cells by Adrien Chouchou, Cindy Patinote, Pierre Cuq, Pierre-Antoine Bonnet, Carine Deleuze-Masquéfa

Get full text

[1,2,4]triazolo[4,3-<i>a</i>]quinoxaline as Novel Scaffold in the Imiqualines Family: Candidates with Cytotoxic Activities on Melanoma Cell Lines by Cindy Patinote, Sandy Raevens, Amélie Baumann, Eloise Pellegrin, Pierre-Antoine Bonnet, Carine Deleuze-Masquéfa

Get full text

Imiquimod Targets Toxoplasmosis Through Modulating Host Toll-Like Receptor-MyD88 Signaling by Maguy Hamie, Rania Najm, Carine Deleuze-Masquefa, Pierre Antoine Bonnet, Jean-François Dubremetz, Marwan El Sabban, Hiba El Hajj

Get full text

EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica. by Rana El Hajj, Hanady Bou Youness, Laurence Lachaud, Patrick Bastien, Carine Masquefa, Pierre-Antoine Bonnet, Hiba El Hajj, Ibrahim Khalifeh

Get full text

EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML by Hala Skayneh, Batoul Jishi, Rita Hleihel, Maguy Hamie, Rana El Hajj, Carine Deleuze-Masquefa, Pierre-Antoine Bonnet, Marwan El Sabban, Hiba El Hajj

Get full text